Triggering MSR1 promotes JNK-mediated inflammation in IL-4 activated macrophages by Guo, Manman et al.
                                                                    
University of Dundee
Triggering MSR1 promotes JNK-mediated inflammation in IL-4 activated macrophages
Guo, Manman; Härtlova, Anetta; Gierlinski, Marek; Prescott, Alan; Castellvi, Josep;
Hernandez Losa, Javier
Published in:
EMBO Journal
DOI:
10.15252/embj.2018100299
Publication date:
2019
Document Version
Publisher's PDF, also known as Version of record
Link to publication in Discovery Research Portal
Citation for published version (APA):
Guo, M., Härtlova, A., Gierlinski, M., Prescott, A., Castellvi, J., Hernandez Losa, J., ... Trost, M. (2019).
Triggering MSR1 promotes JNK-mediated inflammation in IL-4 activated macrophages. EMBO Journal, 38(11),
1-15. [e100299]. https://doi.org/10.15252/embj.2018100299
General rights
Copyright and moral rights for the publications made accessible in Discovery Research Portal are retained by the authors and/or other
copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with
these rights.
 • Users may download and print one copy of any publication from Discovery Research Portal for the purpose of private study or research.
 • You may not further distribute the material or use it for any profit-making activity or commercial gain.
 • You may freely distribute the URL identifying the publication in the public portal.
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 24. Nov. 2019
Article
Triggering MSR1 promotes JNK-mediated
inflammation in IL-4-activated macrophages
Manman Guo1,†,‡ , Anetta Härtlova1,2,3,4,†,* , Marek Gierlinski5, Alan Prescott6, Josep Castellvi7,
Javier Hernandez Losa7,8, Sine K Petersen3,4, Ulf A Wenzel3,4, Brian D Dill1, Christoph H Emmerich1,
Santiago Ramon Y Cajal7,8, David G Russell9 & Matthias Trost1,2,**
Abstract
Alternatively activated M2 macrophages play an important role in
maintenance of tissue homeostasis by scavenging dead cells, cell
debris and lipoprotein aggregates via phagocytosis. Using proteo-
mics, we investigated how alternative activation, driven by IL-4,
modulated the phagosomal proteome to control macrophage
function. Our data indicate that alternative activation enhances
homeostatic functions such as proteolysis, lipolysis and nutrient
transport. Intriguingly, we identified the enhanced recruitment of
the TAK1/MKK7/JNK signalling complex to phagosomes of IL-4-acti-
vated macrophages. The recruitment of this signalling complex was
mediated through K63 polyubiquitylation of the macrophage scav-
enger receptor 1 (MSR1). Triggering of MSR1 in IL-4-activated
macrophages leads to enhanced JNK activation, thereby promoting
a phenotypic switch from an anti-inflammatory to a pro-inflamma-
tory state, which was abolished upon MSR1 deletion or JNK inhibi-
tion. Moreover, MSR1 K63 polyubiquitylation correlated with the
activation of JNK signalling in ovarian cancer tissue from human
patients, suggesting that it may be relevant for macrophage pheno-
typic shift in vivo. Altogether, we identified that MSR1 signals
through JNK via K63 polyubiquitylation and provides evidence for
the receptor’s involvement in macrophage polarization.
Keywords macrophage scavenger receptor 1; phagosome; proteomics;
scavenger receptor; tumour-associated macrophages
Subject Categories Post-translational Modifications, Proteolysis & Proteo-
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Introduction
Phagocytosis is a highly conserved process essential for host
defence and tissue remodelling. It involves the recognition of parti-
cles by a variety of cell surface receptors, followed by cargo process-
ing and delivery to lysosomes via phagosome–lysosome fusion,
process known as phagosome maturation. This leads to gradual
acidification of the phagosomal lumen and acquisition of digestive
enzymes required for the degradation of phagosomal cargo. There-
fore, phagocytosis is not only responsible for elimination of bacterial
pathogens, but also responsible for the clearance of apoptotic cells,
cell debris and senescence cells and orchestrates the subsequent
immune response (Rothlin et al, 2007; Murray & Wynn, 2011;
Lemke, 2013, 2017). Central to this process is phagosome function.
If uncontrolled, the inappropriate clearance of apoptotic bodies can
give rise to autoimmune diseases, atherosclerosis and cancer, while
failure to ingest or kill pathogens can result in deadly infections
(Johnson & Newby, 2009; Nagata et al, 2010; Colegio et al, 2014;
Arandjelovic & Ravichandran, 2015). Therefore, it is of great impor-
tance to understand which signalling pathways regulate phagocyto-
sis and phagosomal maturation.
It has recently been acknowledged that the phagosome serves as
a signalling platform and interacts with innate immune signalling
(Stuart et al, 2007; Martinez et al, 2011, 2015; Kagan, 2012; Heck-
mann et al, 2017). However, whether phagosome-associated cell
signalling is independent of its role in cargo degradation has not
been well understood. Supporting this notion, recent proteomic
studies demonstrated that phagosomes are dynamic organelles that
change their composition and function in response to infection or
inflammation (Trost et al, 2009; Boulais et al, 2010; Dill et al, 2015;
Guo et al, 2015; Naujoks et al, 2016; Hartlova et al, 2018). While
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the regulation of phagosomal maturation in so-called M1 inflamma-
tory macrophages has been extensively studied, the mechanisms
facilitating phagosomal maturation in macrophages involved in
tissue repair remain poorly understood (Balce et al, 2011).
Th2-derived cytokines, such as interleukin-4 (IL-4) and inter-
leukin-13 (IL-13), induce a strong anti-inflammatory macrophage
phenotype, also called alternative-activated macrophages (M2). M2
macrophages and tissue-resident macrophages, which often
resemble an M2-like state, clear cell debris and dead cells through
phagocytosis. They are therefore essential for maintenance and
tissue homeostasis. M2 alternatively activated macrophages (AAMs)
inhibit inflammatory responses and promote angiogenesis and
tissue repair by synthetizing mediators required for collagen deposi-
tion, which is important for wound healing (Gordon & Martinez,
2010). It has been shown that IL-4 enhanced phagosomal protein
degradation (Balce et al, 2011). Whether IL-4 regulates other phago-
somal functions, and through which molecular mechanisms,
remains unclear.
Here, we investigated the phagosome proteome of IL-4-activated
macrophages. In line with the known role in homeostasis, the
phagosome of AAMs has increased abilities to degrade incoming
apoptotic cells and transport the resulting nutrients. Furthermore,
we demonstrate that the TAK1/MKK7/JNK signalling complex
showed an enhanced association with the phagosome upon IL-4
macrophage activation. The assembly of the signalling complex is
mediated through K63 polyubiquitylation. By combining K63-polyu-
biquitylation enrichment and mass spectrometry approaches, we
identified macrophage scavenger receptor 1 (MSR1) as the upstream
receptor that promotes the recruitment of the TAK1/MKK7/JNK
signalling complex to the phagosome. Triggering MSR1 induces JNK
activation in M2 macrophages. This MSR1/JNK signalling pathway
activation leads to a M2/M1 macrophage phenotypic switch that is
abolished in macrophages lacking MSR1. We demonstrate that
MSR1 is K63-ubiquitylated and signals through JNK in human
patient ovarian cancer, thus suggesting a potential role in human
cancer.
Results
Alternative activation regulates phagosomal proteolysis and
lipolysis
To determine the impact of IL-4 on phagocytosis and phagosomal
functions, we examined the rate of phagocytosis and phagosomal
functions in IL-4 AAMs (M2) and resting macrophages (M0). We
found that both IL-4- and IL-13-activated M2 macrophages have
enhanced uptake of apoptotic cells, while uptake of necrotic cells
was comparable to M0 resting macrophages (Fig 1A). To determine
whether the enhanced uptake was because of the negative charge of
apoptotic cells, we compared the uptake of fluorescently labelled
carboxylated negatively charged and positively charged amino silica
microspheres in M2 and M0 macrophages. The analysis revealed an
increased uptake of negatively charged microspheres in M2 macro-
phages, which are taken up through scavenger receptors (Tanaka
et al, 1996; Platt et al, 1999; Stephen et al, 2010), while the
engulfment of positively charged microspheres was similar to M0
macrophages (Fig 1B). This indicates that, due to their similar
uptake behaviour, carboxylated microspheres may serve as a
surrogate for apoptotic cells (Kiss et al, 2006). Next, we analysed
the functional parameters of the phagosomal lumen. In these assays,
we use fluorescent probes that allow the measurement of proteolysis
(a readout for maturation), acidification and lipolysis in real time
(Yates et al, 2005; Podinovskaia et al, 2013). Consistent with the
previous reports, we observed enhanced proteolytic activity in
phagosomes of M2 macrophages (Balce et al, 2011). Furthermore,
we found that IL-4 increased phagosomal lipid degradation and
facilitated phagosomal acidification (Fig 1C–E) indicating that IL-4
activation promotes phagosome maturation and the ability of
macrophages to degrade lipid-rich particles through phagosomes.
Altogether, these data indicate that that alternative activation
increases the ability to take up and degrade apoptotic cells and other
lipid-rich particles by increasing the degradative potential of
phagolysosomes from M2 (IL4) MΦs.
Quantitative proteomic analysis of phagosomes from IL-4
alternatively activated macrophages
To obtain further molecular details about the changes on phago-
somes of M2 macrophages, we isolated highly pure phagosomes
from M2 and M0 macrophages by floatation on a sucrose gradient
using carboxylated microspheres and analysed their proteomes by
quantitative LC-MS/MS (Fig 2A; Appendix Figs S1A–C and S2A;
Desjardins et al, 1994; Peltier et al, 2017; Trost et al, 2009).
Comparative analysis led to the identification of 20,614 distinct
peptides corresponding to 1,948 unique proteins across three inde-
pendent replicates at a false-discovery rate (FDR) of < 1%, of
which 1,766 proteins were quantified in at least two of the three
biological replicates. IL-4 activation induced strong changes to the
phagosome proteome with 121 proteins significantly up-regulated
and 62 proteins significantly down-regulated (twofold change,
P < 0.05; Fig 2B; Dataset EV1), some of which we validated by
Western blot analysis (Appendix Fig S2B). Consistent with the
above observations, a subset of proteins involved in lipid metabo-
lism (Lpl lipoprotein lipase, ABHD12 lipase and phospholipase
D1), acidification (v-ATPase complex) and lysosomal enzymes
including cathepsins L1 and D were highly enriched on the phago-
some of M2 macrophages (Fig 2C; Dataset EV1). Moreover, GO
term (Fig 2D) and protein network analysis (Appendix Fig S2C)
further showed that IL-4 alternative activation also increased
phagosome abundance of scavenger receptors such as MARCO,
CD36, Colec12 and MSR1 required for clearance of dead cells while
Toll-like receptors (TLRs) involved in inflammatory response were
reduced (Fig 2D, Appendix Fig S2C). Furthermore, M2 phagosomes
showed higher phosphatidylinositol-binding proteins, suggesting
changes to the phagosome membrane lipid content (Fig 2D).
Consistent with a previous report, superoxide anion generation
including the NADPH oxidase complex proteins NCF1 (p47-phox),
Cyba (p22-phox), Cybb (gp91-phox) and superoxide dismutase
SOD1 was strongly down-regulated in phagosomes from M2
macrophages (Fig 2D, Appendix Fig S2C; Balce et al, 2011). Inter-
estingly, M2 macrophages also enriched a large number of specific
carbohydrate-binding proteins such as lectins, while carbohydrate
hydrolases were significantly reduced. This indicates a conserva-
tion of phagocytosed glycans, potentially for antigen presentation
via MHC class II molecules (Avci et al, 2013). Taken together,
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these results indicate that the phagosome of M2 macrophages has
mainly a homeostatic role with its increased ability to hydrolyse
proteins and lipids of incoming cargo.
TAK1/MKK7/JNK is recruited to the phagosome of M2
macrophages via K63 polyubiquitylation
Interestingly, anti-inflammatory IL-4 activation also led to an
increased phagosome abundance of the pro-inflammatory MAP
kinase signalling complex around TAK1 (Map3k7, 2.1-fold) and
MKK7 (Map2k7, 3.1-fold; Dataset EV1; Appendix Fig S2C) indicating
cross-regulation between anti- and pro-inflammatory pathways.
Given the increased abundance of these pro-inflammatory kinases
was surprising on phagosomes of IL-4-stimulated macrophages, we
next investigated how this complex was translocated to the phago-
some. Immunoblot analyses of total cell lysates and phagosomal
fractions revealed significant enrichment of TAK1 and MKK7 on
phagosomes of M2 macrophages compared to resting M0 macro-
phages (Fig 3A and B). Activated TAK1 can phosphorylate two
MAPK kinases, MKK4 and MKK7, which both can activate JNK.
While MKK4 can activate p38 and JNK MAPK signalling pathways,
MKK7 selectively activates JNK (Tournier et al, 2001). Noteworthy,
our mass spectrometry data revealed that only MKK7 was enriched
on phagosomes upon IL-4 alternative activation. Consistent with
our LC-MS/MS data, MKK4 was not detected on phagosomes of M2
macrophages by immunoblot analysis indicating that MKK7 alone
was important in this phagosome signalling pathway. Further
immunoblot analysis also confirmed enrichment of JNK of M2
macrophage phagosomes (Appendix Fig S4C).
Previous data have shown that upon pro-inflammatory inter-
leukin-1 receptor or Toll-like receptor (TLR) activation, the TAK1/
MKK7/JNK complex binds to the TAB1/TAB2 protein complex,
which in turn is recruited to K63-polyubiquitin chains (Xia et al,
2009; Emmerich et al, 2013). We next tested whether TAB1/TAB2 is
recruited to the phagosome of M2 macrophages. Indeed, immuno-
blot analysis demonstrated enrichment of TAB1/TAB2 on phago-
somes of M2 macrophages compared to M0. To further validate the
recruitment of the protein complex to phagosomes, we performed
confocal fluorescence microscopy and showed vesicular distribution
in the cytoplasm with enhanced recruitment of TAB1, TAB2 and
MKK7 to the M2 macrophage phagosome compared to M0 macro-
phages (Appendix Fig S3A and B).
As it is well-established that TAK1 binds via TAB1/2/3 to free
and protein-anchored K63-polyubiquitin chains in inflammatory
A
C D E
B
Figure 1. Alternative activation affects phagosomal proteolysis and lipolysis as well as phagocytosis of negatively charged particle.
A Phagocytosis assay of apoptotic or necrotic GFP-expressing RAW264.7 cells in M2 (IL-4 or IL13) and untreated M0 BMDMs.
B Phagocytosis of fluorescent negatively charged carboxylated and positively charged amino microspheres (B) in primary M2 (IL-4) and M0 macrophages.
Cytochalasin D (Cyto) (6 lM) was used as an inhibitor of phagocytosis, 1 h before phagocytosis.
C–E Real-time fluorescence assays for intraphagosomal proteolysis (C), acidification (D) and lipolysis (E) show substantially increased proteolysis, acidification and
lipolysis in the phagosomes of M2 (IL-4) macrophages. The kinetics of proteolysis, acidification and lipolysis of phagocytosed beads were plotted as a ratio of
substrate fluorescence to calibration fluorescence. Beads were added to macrophages at 0 min. (E) is a representative of three independent experiments. Leupeptin
(100 nM) and bafilomycin (100 nM) treatments serve as negative controls in (C) and (D), respectively.
Data information: The statistical significance of data is denoted on graphs by asterisks where *P < 0.05, ***P < 0.001 or ns = not significant. (A, B) Data are shown as
means of relative fluorescence units (RFU)  standard error of the mean (SEM), Student’s t-test used. (C, D) Shaded area represents SEM. (A–D) Three replicates were used.
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Figure 2. Experimental workflow and the phagosome proteome of M2 (IL-4) macrophages.
A Workflow of the phagosome proteomic experiment.
B Volcano plot of the phagosome proteome data. 1,766 proteins were quantified of which 121 proteins were significantly up-regulated and 62 proteins were down-
regulated in M2 (IL-4) macrophages. Selected proteins are indicated.
C Heatmap of proteomic data shows high reproducibility between biological replicates. Selected proteins are highlighted.
D Selected Gene Ontology (GO) terms of biological processes significantly up-regulated and down-regulated on phagosomes of M2 (IL-4) macrophages. Selected
proteins of these GO-terms are highlighted. Error bars represent standard deviations from three biological replicates.
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innate immune responses (Xia et al, 2009; Emmerich et al, 2013),
we tested whether phagosomes from M2 macrophages contain
K63-polyubiquitylated proteins independent of inflammatory stim-
uli. Immunoblot analysis of phagosome extracts probed with
anti-K63-polyubiquitin antibodies revealed that phagosomes
contain a large amount of K63-polyubiquitylated proteins
compared to the total cell lysate, which was even more increased
by alternative activation (Fig 3C). To determine whether recruit-
ment of TAB1, TAB2, TAK1 and MKK7 to the M2 phagosome was
indeed K63-polyubiquitylation-dependent, we treated cells with
A
C D
B
Figure 3. TAK1/MKK7/JNK complex is recruited to phagosomes of M2 (IL-4) macrophages in a K63-polyubiquitylation-dependent manner.
A Immunoblot (IB) analysis showing the recruitment of TAK1, MKK7, JNK and TAB1/TAB2 to the phagosome in M2 (IL-4) macrophages, while MKK4 is not recruited.
Rab7a, a phagosomal marker, was used as a loading control for phagosomes, and vimentin was used as a loading control for total cell lysates. The white line in the
JNK blot shows other bands were cut out. Full blot can be seen in Appendix Figure S4.
B Quantitation of three independent IB experiments by ImageJ of non-saturated blots for TAK1, MKK7, TAB1 and TAB2 expression on phagosomes of resting M0
macrophages and M2 (IL-4) macrophages. Error bars represent SEM. *P < 0.01, **P < 0.001 (Student’s t-test). Three replicates were used.
C IB showing enrichment of K63-polyubiquitylated proteins on the phagosome of M2 (IL-4) macrophages compared to M0 macrophages.
D Treatment with the UBC13 inhibitor NSC697923 reduces recruitment of TAB1, TAB2, TAK1 and MKK7 to the phagosome of M2 (IL-4) macrophages, indicating a K63-
polyubiquitylation-dependent translocation for these proteins.
Data information: (C) and (D) are representatives of three and two independent experiments, respectively.
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NSC697923, a pharmacological inhibitor of the K63-specific
E2-conjugating enzyme UBC13-UEV1A (Pulvino et al, 2012) and
probed isolated phagosomes for K63 polyubiquitylation. As shown
in Fig 3D, recruitment of the protein complex was virtually abol-
ished under these conditions, which we also confirmed for MKK7
by immunofluorescence microscopy (Appendix Fig S4A and B).
These data indicate that IL-4 activation of macrophages promotes
K63 polyubiquitylation, which recruits the TAK1/MKK7/JNK
complex to the phagosome.
Macrophage scavenger receptor 1 is K63-polyubiquitylated
and interacts with TAK1/MKK7/JNK on the phagosome of
M2 macrophages
In order to identify the K63-polyubiquitylated proteins, which
bind the TAK1/MKK7/JNK complex on the phagosome of M2
macrophages, we enriched polyubiquitylated phagosomal proteins
from M2 macrophages using tandem ubiquitin-binding entities
(TUBEs) of a repeat of the Npl4 Zinc Finger (NZF) domain of
TAB2 tagged with Halo (termed here Halo-TAB2). These
constructs have been shown to bind specifically to K63-polyubi-
quitin chains (Fig 4A; Hjerpe et al, 2009; Emmerich et al, 2013;
Heap et al, 2017). Quantitative mass spectrometric analysis of
these pull-downs identified 538 phagosomal proteins that were
reproducibly captured by Halo-TAB2 compared to mutant, ubiqui-
tin-non-binding Halo (T674A/F675A) TAB2 control beads (based
on a twofold, P < 0.05 cut-off; Dataset EV2). Moreover, we identi-
fied 62 novel direct ubiquitylation (GlyGly) sites on 33 different
phagosomal proteins. Quantitation of the data revealed that the
Gly-Gly peptide derived from K63-linked polyubiquitin was by far
the most abundant, proving that we achieved good enrichment.
However, we also identified peptides for K11-, K48-, linear/M1-,
K29-, K6-, K27- and K33 (in order of decreasing abundances)-
linked polyubiquitin, suggesting that there are either mixed chains
or K63-polyubiquitylated proteins might also be modified with
other polyubiquitin chains.
Other identified ubiquitylated proteins included many known
phagolysosomal proteins such as the large neutral amino acid trans-
porter SLC43A2/LAT4 (K283, K293, K402, K557), the cholesterol
transporter ABCG1 (K55), Fc- and B-cell receptor adaptor LAT2
(K39, K84), LYN kinase (K20) and the TLR chaperone UNC93B1
(K197, K582; Fig 4B; Appendix Table S1).
Interestingly, one of the most abundant Gly-Gly-modified
peptides was a peptide containing lysine 27 (K27) of macrophage
scavenger receptor 1/scavenger receptor A (MSR1/SR-A; CD204).
This site is highly conserved between human and mouse (Fig 4C).
MSR1 is a multifunctional phagocytic receptor, highly expressed in
macrophages, involved in uptake of apoptotic cells and modified
lipoproteins (Kelley et al, 2014). In addition to its scavenging func-
tion, MSR1 has been implicated in the innate immune response to
bacteria (Platt & Gordon, 2001).
Our MS and immunoblot data showed an increase in MSR1 on
phagosomes from M2 macrophages compared to M0 macrophages
(Dataset EV1; Appendix Fig S5A and C), while both total cell and
cell surface expression levels of MSR1 were unchanged between the
two conditions (Appendix Fig S5B). However, when we precipitated
K63-polyubiquitylated proteins from resting and M2 macrophages,
we could see that the polyubiquitylated forms of MSR1 were
considerably more abundant in alternatively activated macrophages
(Fig 4D), suggesting that MSR1 becomes more polyubiquitylated in
M2 macrophages.
To validate K63 polyubiquitylation of MSR1, we treated enriched
polyubiquitylated phagosome protein extracts from M2 macro-
phages with the K63-specific deubiquitylase (DUB) AMSH-LP or the
non-specific DUB USP2 (Ritorto et al, 2014; Fig 4E). In both cases,
the high molecular smear of ubiquitylated MSR1 decreased while
the band representing the non-ubiquitylated form of MSR1 increased
significantly, indicating that MSR1 was predominantly K63-polyubi-
quitylated on phagosomes upon uptake of carboxylated beads in M2
macrophages.
We next investigated whether K63-polyubiquitylated MSR1 might
recruit the TAB1/TAB2/TAK1/MKK7 complex to the phagosome.
To test this, we pulled down MSR1 from extracts of carboxylated
bead phagosomes. We found that indeed TAB1/TAB2/TAK1/MKK7
complex co-immunoprecipitated with MSR1 (Fig 4F). Moreover,
using a different antibody against TAK1, immunoblot analysis
patterns indicated also substantial post-translational modification—
most likely polyubiquitylation—of TAK1, which was considerably
enhanced in MSR1 IPs. It has been reported that ubiquitylation of
TAK1 activated the kinase activity (Fan et al, 2010), suggesting that
TAK1 and the downstream kinase MKK7 are recruited in the active
state or activation is triggered by binding to K63-polyubiquitylated
MSR1. Taken together, these data demonstrate that phagosomal
MSR1 becomes K63-polyubiquitylated upon activation in IL-4-acti-
vated macrophages, which recruits the TAK1/MKK7 kinase signal-
ling complex.
Triggering MSR1 activates JNK pathway
To further test whether the engagement of MSR1 causes the acti-
vation of the TAK1/MKK7/JNK pathway, wild-type (WT) and
MSR1 KO M2 macrophages were stimulated with the MSR1
ligands fucoidan and oxidized LDL (oxLDL) and analysed for
MSR1 K63 polyubiquitylation and activation of JNK signalling
(Greaves & Gordon, 2009). Pull-downs of ubiquitylated proteins
were blotted for MSR1, which revealed that MSR1 activation
increased the amount its polyubiquitylation. Moreover, M2
macrophages deficient in MSR1 showed decreased JNK phospho-
rylation upon fucoidan or oxLDL stimulation (Fig 5A and B),
indicating that MSR1 directly signals through the JNK signalling
pathway. Furthermore, JNK activation was dependent on MSR1
polyubiquitylation, as K27R mutation of MSR1 abolished JNK
activation in response to fucoidan in IL-4-activated macrophages
(Fig 5C). This prompted us to test whether MSR1 signalling
through the JNK kinase complex plays a role in affecting the
inflammatory state of macrophages by characterizing gene expres-
sion and cell surface markers. Ablation of MSR1 resulted in
diminished induction of the pro-inflammatory genes Il1b, Tnfa
and Ccl2 in response to fucoidan in M2 macrophages (Fig 5D).
Consistently, MSR1 KO M2 macrophages exhibited reduced cell
surface expression of pro-inflammatory markers CD69, CD86 and
CD54 while the M2-cell surface markers CD36 and CD301b
(Mgl2) remained unperturbed or even reduced upon MSR1 liga-
tion (Fig 5F; Appendix Figs S6A and S7). This increase in pro-
inflammatory state was abolished by treatment with the specific
JNK inhibitor JNK-IN8 (Zhang et al, 2012; Fig 5E, Appendix Fig
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Figure 4. Phagosomal MSR1 is K63-polyubiquitylated and interacts with Tab1/Tab2/Tak1/MKK7.
A Workflow for TUBE pull-down of K63-polyubiquitylated proteins from phagosomal extracts.
B Selected ubiquitylated phagosomal proteins identified by TUBE-MS approach.
C Sequences alignment of N-terminal region of murine and human MSR1 shows high-sequence identity and conserved ubiquitylated lysine. The arrow points out the
ubiquitylated lysine residue.
D Tab2-TUBE pull-downs from phagosome extracts of M2 (IL-4) macrophages treated with the K63-specific deubiquitylase (DUB) AMSH-LP or the unspecific DUB USP2.
E MSR1 immunoprecipitation from M2 (IL-4) macrophage phagosomes shows that TAB1, TAB2, TAK1 and MKK7 bind to polyubiquitylated MSR1. TAK1 shows a specific
pattern of post-translational modifications indicative of its activation.
Data information: (D) and (E) are representative of two independent experiments.
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S6B and C). This process was dependent on specific MSR1
ligands as stimulation with Toll-like receptor 4 (TLR4)-activating
lipopolysaccharide (LPS) and IFN-c did not show any differences
between WT and MSR1 KO macrophages (Appendix Fig S6A)
suggesting the involvement of the MSR1-JNK pathway in pheno-
typic switch. Finally, by blotting for the NF-kappa-B inhibitor
alpha (IjBa) we could show that triggering MSR1 was not acti-
vating the NF-jB pathway (Appendix Fig S8). These data show
that triggering of MSR1 in alternatively activated macrophages
leads to the enhanced activation of the JNK signalling pathway,
which induces a pro-inflammatory phenotype switch in these
macrophages.
A
D
F
E
B C
Figure 5. MSR1 triggering activates JNK, which induces a pro-inflammatory stimulus.
A Immunoblot against MSR1 of TUBE pull-downs of MSR1 WT and KO BMDMs shows increasing amounts of ubiquitylated MSR1 upon alternative activation and
further increases upon MSR1 ligation with fucoidan or oxLDL.
B Msr1+/+ (WT) and Msr1/ (KO) M0 macrophages and M2 (IL-4) macrophages untreated or stimulated with the MSR1 ligands fucoidan or oxLDL (50 lg/ml, 30 min)
were analysed for the phosphorylated and the total forms of JNK1/2 and MSR1. ITGAM (CD11b) serves as a loading control. Both fucoidan and oxLDL activate JNK in a
MSR1-dependent manner.
C IL4-activated MSR1 knock-out BMDMs were transfected with WT or K27R MSR1 and treated with 50 lg/ml fucoidan for 1 h. Mutation of the ubiquitylation site K27
abolishes MSR1 signalling.
D qPCR data of Tnfa, Il1b and Ccl2 mRNA levels in WT and MSR1 KO M0 and M2 (IL-4) BMDMs show an MSR1-dependent increase in pro-inflammatory cytokines in
response to MSR1 ligation by fucoidan.
E Inhibition of JNK by JNK-IN8 reduces expression of Tnfa and Ccl2 upon MSR1 ligation, showing that it is JNK-dependent.
F Flow cytometry analysis of cell surface markers in WT and MSR1/ M0 macrophages and M2 (IL-4) macrophages untreated or stimulated with the MSR1 ligands
fucoidan (50 lg/ml, 24 h). Data show MSR1-dependent increase in the early activation markers CD54, CD69 and CD86 and a decrease in the M2 marker CD301b/Mgl2.
CD11b serves as a control.
Data information: Error bars represent SEM. ***P < 0.0001; ****P < 105 (Student’s t-test). (A, B) Data are representative of three independent experiments. (D, E, F)
Three biological replicates.
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MSR1 is polyubiquitylated in human
tumour-associated macrophages
Next, we wanted to test whether MSR1 ubiquitylation was also
present in settings of human disease. MSR1 has been implicated in
tumour development and progression (Komohara et al, 2009; Chan-
mee et al, 2014), and tumour-associated macrophages (TAMs) have
been shown to resemble M2 macrophage phenotype with MSR1
protein expression (Sica et al, 2007). However, the role of MSR1 in
TAMs is not fully understood. We characterized five human patient
samples with different types of cancers for the presence of MSR1.
These tissue samples showed a high variability in the number of
TAMs that stained positively for MSR1 using immunohistochemistry
(Fig 6A). Consistent with the human proteome atlas data (http://
www.proteinatlas.org/ENSG00000038945-MSR1/cancer), we found
particularly high expression of MSR1 in patient ovarian cancer.
Interestingly, the TAMs of the patient with ovarian cancer also
showed increased levels of ubiquitylated MSR1 as well as enhanced
phosphorylation of JNK and its substrate c-Jun (Fig 6B). This
suggests that JNK signalling downstream of polyubiquitylated MSR1
is present in TAMs of human cancers and could potentially be
involved in tumour promotion.
Discussion
Macrophages are highly diverse and plastic immune cells that can
polarize in response to environmental cues into many different
phenotypes. Because of their important and diverse functions in
regulating immune responses and metabolism, dysregulated macro-
phage polarization is frequently associated with disease (Schultze
et al, 2015). Here, we expand our understanding of macrophage
phenotype switching by showing on the molecular level that
engagement of MSR1 in IL-4-activated macrophages results in the
activation of the JNK signalling pathway, thereby inducing a shift
from an anti-inflammatory to a pro-inflammatory phenotype.
A B C
Figure 6. MSR1 ubiquitylation and JNK activation correlate in human tumour-associated macrophages.
A Immunohistochemistry analysis of MSR1 in patient ovarian, uterus and sarcoma cancers showing tumour-associated macrophages.
B Pull-downs of K63-polyubiquitin chains and IB analysis of five human primary cancers show a correlation between the amount of polyubiquitylated MSR1 and JNK
activation in an ovarian tumour.
C Working model: MSR1 is activated by ligation through many different substrates, including apoptotic cells, fucoidan or oxidized LDL (Signal 1). However, only when
the macrophage is IL-4-activated (Signal 2) becomes MSR1 ubiquitylated by an unknown E2/E3 ligase. This ubiquitylation recruits Tab2/3, Tak1, Mkk7 and finally JNK,
thereby allowing MSR1 to signal directly through the JNK signalling pathway which induces pro-inflammatory gene transcription.
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Recent data imply that distinct pathways regulate uptake kinetics
of different particles as well as phagosome functions in macrophages,
and these are further controlled by macrophage activation. It was
demonstrated that both the phagocytic receptors (Dill et al, 2015;
Balce et al, 2016) and pro-inflammatory (Yates et al, 2007; Trost
et al, 2009; Ghigo et al, 2010) and anti-inflammatory activation
(Varin et al, 2010; Balce et al, 2011) of macrophages affect phago-
some functions and these are regulated by signalling pathways such
as kinases (Hartlova et al, 2018) and E3 ligases (O. Bilkei-Gorzo, T.
Heunis, A. Ha¨rtlova, M. Trost, unpublished data).
A striking finding from our study is the identification of increased
ubiquitylation on the phagosome. Ubiquitylation in the endo-lyso-
somal system is generally thought to be important for lysosomal
degradation of membrane proteins (Piper et al, 2014). Our data indi-
cate that K63 polyubiquitylation on phagosomal proteins is also
used as a scaffold for the recruitment of signalling complexes, in
particular the kinase complex TAK1/MKK7/JNK to MSR1 via speci-
fic polyubiquitylation on a conserved lysine K27. Remarkably, we
could show that only MKK7 and not MKK4 is recruited to this
signalling complex in IL-4-activated macrophages, showing a dif-
ferent role for the two MAP kinase kinases in activating JNK.
It is noteworthy that MSR1 is in almost equal abundance in rest-
ing, alternatively and classically activated macrophages, but its
abundance increases on the phagosome of activated macrophages.
This indicates that macrophage activation (as signal 1) induces
translocation of MSR1 and activation/transcription/translocation of
an E3 ligase. This unknown E3 ligase then ubiquitylates the receptor
after MSR1 ligation (signal 2), thereby enabling pro-inflammatory
signalling through the TAK1/MKK7/JNK signalling complex
(Fig 6C). During inflammatory conditions, when TLR or IL1R is acti-
vated, this signalling probably does not add substantially to the
macrophage phenotype as TLR activation is much stronger a
pro-inflammatory signal. However, in M2 or tissue-resident macro-
phages with a similar M2-like phenotype, prolonged MSR1 ligation
could lead to a pro-inflammatory switch of these macrophage
subsets via JNK. Interestingly, recent data in Drosophila showed
that apoptotic corpses prime macrophages for detection of tissue
damage and that this priming and subsequent recruitment to
wounds were dependent on JNK (Weavers et al, 2016). Moreover, it
has been shown before that JNK plays an important role in obesity-
induced inflammation (Han et al, 2013). This suggests that JNK
activation induced by uptake apoptotic bodies or lipids through
MSR1 could regulate various responses.
MSR1 has in recent years been established as a good marker for
TAMs (Allavena & Mantovani, 2012) which resemble rather a M2
alternatively activated phenotype and have been associated with
tumour promotion (Sica et al, 2007). While previously it was shown
that lack of MSR1 delayed the growth of EL4 lymphoma in mice by
increased pro-inflammatory responses to necrotic cells (Komohara
et al, 2009), our data revealed an increased expression of K63-poly-
ubiquitylated MSR1 in a human ovarian cancer. This coincided with
increased activation of JNK pro-inflammatory signalling pathway,
suggesting that the MSR1-JNK signalling pathway is activated in the
progression of cancer. Interestingly, MSR1 has been previously
shown to promote tumour progression and metastasis in ovarian
and pancreatic cancer mouse models (Neyen et al, 2013), suggesting
that MSR1 and downstream signalling may be a potential drug
target in the prevention of cancer metastasis progression.
Materials and Methods
Antibodies
The following antibodies were purchased from Cell Signalling Tech-
nology: pSTAT1 (#8826), Arginase-1 (#9819), Rab7 (#9367), Rab5
(#2143), BIP (#3183), EEA1 (#2411), IjBa (#9242), LAMP1 (#3243),
Na+/K+ ATPase 1 (#3010), Lamin A/C (#2032), TAK1 (#4505),
JNK (#9258), p-JNK (#9251), p-c-Jun (#9165) and Vimentin
(#5741). Antibodies purchased from Abcam were as follows:
pSTAT6 (ab54461), CD36 (ab133625), CD14 (ab182032) and MSR1
(ab151707, ab79940). Antibodies against K63-specific ubiquitin
(#05-1308) and ITGAM (PAB12135) were from Millipore and
Abnova, respectively. Sheep antibodies against MSR1, TAK1, TAB1,
TAB2, MKK7 and MKK4, and rabbit IgG were generated by the Anti-
body Production Team of the Division of Signal Transduction Ther-
apy (DSTT), Medical Research Council Protein Phosphorylation and
Ubiquitylation Unit, University of Dundee, United Kingdom. The
antibody used for MSR1 immunohistochemistry was clone SRA-E5
(from Abnova, #MAB1710). Commercial antibodies were used
according to the manufacturer instructions. DSTT-made antibodies
were used at 2 lg/ml in TBS-T containing 5% non-fat-dried milk.
Recombinant proteins, plasmids and antibodies generated for the
present study are available to request on our reagents website
(https://mrcppureagents.dundee.ac.uk/).
Culturing and activation of bone marrow-derived macrophages
Bone marrow cells were collected from femurs and tibiae of 6- to 8-
week-old C57BL/6 wild-type (WT) or MSR1/SR-A knock-out mice
(kindly provided by Siamon Gordon). The cells were treated with
red blood cell lysis buffer (155 mM NH4Cl, 12 mM NaHCO3,
0.1 mM EDTA) and plated on tissue culture plastic (Corning Incor-
porated) for 3 days in DMEM (Gibco) containing 10% FBS, 2 mM
glutamine, 100 units/ml penicillin–streptomycin (Gibco) and 20%
L929 conditioned supplement. At day 3, the cells in supernatant
were transferred to untreated 10-cm Petri dishes (BD Biosciences)
for 7 days for the differentiation into bone marrow-derived macro-
phages (BMDMs). Then, BMDMs were treated by either IL-4 (20 ng/
ml, BD Pharmingen) for 48 h to get M2 (IL-4) macrophages
(Appendix Fig S1).
Phagosome isolation
For proteomic analysis, phagosomes were isolated from BMDMs
according to previous methods (Desjardins et al, 1994; Trost et al,
2009). Latex beads of 0.8 lm (Estapor/Merck, Fontenay Sous Bois,
France) were diluted 1:50 in complete DMEM media and incubated
with treated and untreated BMDMs for 30 min at 37°C, 5% CO2.
Cells were then harvested on ice, washed in cold PBS, and phago-
somes were isolated as described in previous works (Trost et al,
2009; Guo et al, 2015). Enriched protein extracts contained < 5%
contamination from other cellular organelles as estimated from
immunoblotting experiments (Appendix Fig S2A).
For pull-down assays, phagosomes were isolated using 1-lm
magnetic beads (Estapor/Merck). Magnetic beads were diluted
1:300 in complete DMEM media and incubated with BMDMs for
30 min.
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Phagosome functional assays
Fluorogenic assays for phagosomal proteolysis, acidification and
lipolysis were adapted from the method from the Russell labora-
tory (Yates et al, 2005; VanderVen et al, 2010; Podinovskaia et al,
2013). For proteolysis and acidification, BMDMs were plated onto
96-well plates at 1 × 105 cells per ml 24 h prior to the experiment.
DQ red BSA (Life Technologies)-coupled or BCECF (Life Technolo-
gies)-coupled carboxylated silica beads (3 lm, Kisker Biotech)
were diluted 1:200 in binding buffer (1 mM CaCl2, 2.7 mM KCl,
0.5 mM MgCl2, 5 mM dextrose, 10 mM hydroxyethyl piperazine
ethane sulfonate (HEPES) and 5% FBS in PBS pH 7.2) and incu-
bated with BMDMs for 3 min at room temperature. Beads were
replaced with warm binding buffer, and real-time fluorescence
was measured at 37°C using a SpectraMax Gemini EM Fluores-
cence Microplate Reader (Molecular Devices), set as maximal read-
ings per well to allow reading time intervals of 2 min. Plots were
generated from the ratios of signal/control fluorescence. For lipoly-
sis, Nucleosil 120-3 C18 reverse-phase HPLC 3 lm silica matrix
was coated with a mixture of neutral lipids containing a fluoro-
genic substrate specific to detect the lipase activity and a calibra-
tion fluorogenic dye. Substrate-labelled beads were incubated with
BMDMs on coverslips for 3 min at room temperature. The cover-
slips were then washed and loaded into quartz cuvettes in binding
buffer. Fluorescent intensities were recorded in real time at 37°C
with a thermostat-regulated QMSE4 spectrofluorometer (Photon
Technologies International, Lawrenceville, NJ, USA) with excita-
tion/emission 342/400 nm for reporter dye and 555/610 nm for
calibration dye.
Phagocytosis assays
Phagocytosis of beads was performed by incubating Alexa Flour 488
BSA-coated silica beads at 1:1,000 dilution with BMDMs in 96-well
plates for 10 min at 37°C. Beads were replaced with 100 ll trypan
blue to quench the fluorescence of non-internalized particles. After
aspirating trypan blue, the fluorescence was measured in a Spec-
traMax Gemini EM Fluorescence Microplate Reader, set at excita-
tion/emission wavelengths 495/519 nm.
Uptake of apoptotic/necrotic cells
Uptake of apoptotic or necrotic cells was performed as follows: GFP-
expressing RAW264.7 cells were induced apoptosis by 50 lM cyclo-
heximide for 24 h or necrosis by repeated freeze/thaw cycles. Both
apoptotic and necrotic cells were vigorously washed in PBS and
then added to BMDMs for 6 h at 37°C, in a phagocyte to target ratio
of approximately 1:5. The percentage of BMDMs that had interacted
with apoptotic cells was quantified by FACS analysis of AF488-posi-
tive cells. A minimum of 50,000 events within the macrophage gate
was acquired.
Sample preparation and mass spectrometry analysis
Phagosome proteins were extracted using 1% sodium 3-[(2-methyl-
2-undecyl-1,3-dioxolan-4-yl)methoxy]-1-propanesulfonate (commer-
cially available as RapiGest, Waters) in 50 mM pH 8.0 Tris, reduced
with 1 mM tris(2-carboxyethyl)phosphine (TCEP), and alkylated by
5 mM iodoacetamide (30 min, room temperature, in the dark)
(Sigma) and then quenched by 10 mM DTT. Protein concentrations
were determined using EZQ protein quantitation kit (Life Technolo-
gies). Samples were then diluted in 50 mM Tris containing 5 mM
calcium chloride to a final concentration of 0.1% RapiGest and were
digested by Trypsin Gold (Promega). RapiGest was removed by
adding trifluoroacetic acid (TFA) to 1%, shaking at 37°C for 1 h and
centrifugation at 14,000 × g for 30 min. Peptides were desalted by
solid-phase extraction using Microspin C-18 (Nest Group), lyophi-
lized and labelled using mTRAQ labelling kit (D0 and D8 Da; AB
Sciex) for phagosomal samples.
Mass spectrometric analyses were conducted similarly as
previously described (Dill et al, 2015; Guo et al, 2015). In detail,
biological triplicates or quadruplicates of mixes of 1 lg of light-
labelled and 1 lg of heavy-labelled samples were analysed on an
Orbitrap Velos Pro mass spectrometer coupled to an Ultimate 3000
UHPLC system with a 50 cm Acclaim PepMap 100 or EasySpray
analytical column (75 lm ID, 3 lm C18) in conjunction with a
PepMap trapping column (100 lm × 2 cm, 5 lm C18; Thermo
Fisher Scientific). Acquisition settings were as follows: lock mass
of 445.120024, MS1 with 60,000 resolution, top 20 CID MS/MS
using Rapid Scan, monoisotopic precursor selection, unassigned
charge states and z = 1 rejected, dynamic exclusion of 60 s with
repeat count 1. Six-hour linear gradients were performed from 3%
solvent B to 35% solvent B (solvent A: 0.1% formic acid, solvent
B: 80% acetonitrile 0.08% formic acid) with a 30-min washing
and re-equilibration step.
Proteome quantification and bioinformatics analysis
The phagosome proteomic dataset of IL-4-activated macrophages
was extracted from a combined analysis of phagosomes from five
different activations states (IL-10, IL-13, IFN-c and IFN-c + IL-4;
PRIDE identifier PXD004520). Only proteins identified and quanti-
fied in the IL-4-treated dataset were extracted from this. Identifi-
cation and quantification were performed using MaxQuant v1.3.0.5
(Cox & Mann, 2008) with variable modifications oxidation (M),
acetyl (protein N-term), deamidation (NQ), two multiplicities with
mTRAQ lysine/N-terminal (D0 and D8) (for phagosome samples) or
label-free and Gly-Gly (K) (for TUBE samples), maximum five modi-
fications per peptide and two missed cleavages. Spectra were
matched to a UniProt-Trembl Mus musculus database (50,543
entries, downloaded 18 October 2012) plus common contaminants.
A reverse database was used for false peptide discovery. Mass accu-
racy was set to 10 ppm for precursor ions and 0.5 Da for ion trap
MS/MS data. Identifications were filtered at a 1% false-discovery
rate (FDR) at the protein and peptide level, accepting a minimum
peptide length of 7. Quantification used only razor and unique
peptides, and required a minimum ratio count of 2. “Re-quantify”
and “match between runs” were enabled. Normalized ratios were
extracted for each protein/condition and used for downstream
analyses.
Statistical analyses were performed in Perseus (v1.3.0.4). t-Test-
based statistics were applied on normalized and logarithmized
protein ratios to extract the significantly regulated proteins. Hierar-
chical clustering was performed in Perseus on logarithmized ratios
of significant proteins using correlation distances and average link-
age to generate the heatmap.
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GO term and network analyses
The H/L log fold changes for all quantifiable proteins in each condi-
tion (in replicates) were tested against the null hypothesis that the
mean log fold change was zero. We used a one-sample t-test with
shrinkage variance of Opgen-Rhein & Strimmer (Opgen-Rhein &
Strimmer, 2007). Each protein was annotated with GO terms from
Mouse Genome Informatics Database (downloaded on 5/11/2014).
Log fold change of each GO term was calculated as the mean of log
fold changes of all proteins annotated with this GO term. The signifi-
cance of this mean, against the null hypothesis that the mean is zero
(i.e. there is no discernible fold change in the GO-term proteins),
was found using a bootstrap technique. A protein sample of the
same size as the GO-term group was randomly selected (without
replacement) from the pool of all quantifiable proteins and its mean
log fold change found. The sampling process was repeated 100,000
times, and the significance P-value was determined as the percentile
of bootstraps where the absolute log fold change was greater than in
the GO-term group. Proteins annotated with given GO terms are
presented in “volcano plots”, showing, for each protein, the mean
log fold change of replicates versus the P-value. The error bars
represent the shrinkage standard error.
Protein networks were extracted from STRING database v10
(Szklarczyk et al, 2015) using only “experiment” and “text-mining”
data. Graphs were generated using Cytoscape v3.3 (Shannon et al,
2003).
Immunoblot analysis
Cells or phagosomes were lysed directly in 2× Laemmli buffer, sepa-
rated on 4-12% Nu-PAGE gels (Invitrogen) and immunoblotted onto
PVDF membranes (Amersham). Membranes were blocked for 1 h in
5% (w/v) skim milk in TBS containing 0.1% (v/v) Tween 20 and
subsequently incubated with different primary antibodies overnight.
After incubation with HRP-labelled secondary antibodies, proteins
were detected using ECL and X-ray films. Immunoblots were quanti-
fied in ImageJ software. For activation of MSR1, WT and MSR1 KO
BMDMs were either stimulated with fucoidan (50 lg/ml, Sigma-
Aldrich) for 1 h alone or with IL-4 (20 ng/ml, RD) for 24 h followed
by fucoidan 50 lg/ml, Sigma-Aldrich) treatment for 1 h.
Transfection of WT MSR1 and MSR1 K27R into BMDMs
MSR1 KO BMDMs were transfected either with 1 lg of pCMV WT-
MSR1-FLAG or with pCMV MSR1-(K27R)-FLAG using Fugene
(Promega) transfection agent for 24 h. Following day, cells were
washed and stimulated with IL-4 (20 ng/ml, RD) for 24 h, followed
by fucoidan (50 lg/ml, Sigma-Aldrich) treatment for 1 h.
Immunofluorescence
Resting and alternative-activated BMDMs were seeded at 1 × 105/
ml on glass coverslips. Silica beads (3 lm, Kisker Biotech) were
phagocytosed for 30 min by using a dilution of 1:1,000 in cell
culture media. Cells were subsequently fixed in 4% paraformalde-
hyde (Affymetrix) and permeabilized by incubating for 5 min with
PBS containing 0.02% NP-40. Rabbit anti-Rab7a antibody was used
at dilution of 1:300 to indicate the phagosomes. To visualize the
phagosomal location of interested proteins, sheep anti-TAK1/TAB1/
TAB2/MKK7 antibodies (DSTT) were used at 4 lg/ml. For inhibi-
tion of Ubc13, BMDMs were stimulated with IL-4 (20 ng/ml) either
alone or in the presence of Ubc13 inhibitor NSC697923 (1 lM,
DSTT) for 24 h. Cells were imaged in a Zeiss LSM 700 confocal
microscope using a ×100 Plan Apochromat objective (NA 1.46) and
an optical section thickness of 0.7 lm. For quantitation, all laser,
pin-hole and gain, etc., settings kept the same for all images. Fields
of cells were selected at random using only the DAPI-stained chan-
nel. Optical sections were taken through the centre of the cell
including the beads and 10 fields collected per coverslip. A region of
interest (ROI) was drawn around each bead-containing phagosome,
the Rab7a ring associated with the bead was included. The green
intensity was collected for the same ROI. The integrated sum of the
red and green intensities in each ROI was collected and expressed as
a ratio. At least 25 individual phagosomes were analysed for each
protein target. DAPI, Green-Alexa 488 (target antigen), Red-Alexa
594 (Rab7a) and DIC channels were all collected, and images were
quantified using the Volocity programme (PerkinElmer).
TUBE pull-down
Phagosomes were isolated from M2 (IL-4) macrophages using
magnetic beads. Phagosomal proteins were solubilized in cell lysis
buffer (50 mM Tris–HCl pH 7.5, 1 mM EGTA, 1 mM EDTA, 1%
Triton X100, 0.27 M sucrose, 0.2 mM PMSF, 1 mM benzamidine),
plus 1% SDS and inhibitors of proteases, phosphatases and deubiq-
uitylases were added freshly. Cell lysates were clarified by centrifu-
gation at 14,000 × g for 30 min at 4°C. The supernatants were
collected, and their protein concentrations were determined by EZQ
protein quantitation kit. For each pull-down, 500 lg of phagosome
lysate was diluted in cell lysis buffer to make a final concentration
of 0.1% SDS, and then incubated with Npl4 Zinc Finger (NZF)
domains of TAB2 (TAB2 [644–692]) coupled beads, which were
previously described (Emmerich et al, 2013). Ubiquitin-binding-
defective mutant TAB2 (T674A/F675A) beads were included as
negative control. After overnight incubation at 4°C, the beads were
washed three times with 50 mM Tris–HCl, pH 8.0, 0.5 M NaCl, 1%
Triton X-100 and eight times with 50 mM Tris–HCl, pH 8.0.
Captured proteins were then eluted by incubation for 15 min with
50 mM Tris–HCl, pH 8.0, 1% RapiGest and 5 mM TCEP and
centrifugation at 1,000 × g for 5 min.
Deubiquitylation assay
The polyubiquitylated proteins captured by Halo-TAB2 beads were
washed twice in reaction buffer (50 mM Tris pH 7.5, 50 mM NaCl,
2 mM DTT). The beads were then incubated with or without
AMSH-LP (5 lM) or USP2 (1 lM) in 30-ll reaction buffer at 30°C
for 1 h. The reaction was quenched by denaturation in 1% LDS.
Eluted proteins were separated on SDS–PAGE and immunoblotted
with anti-MSR1 or anti-K63-pUb chain antibodies.
MSR1 co-immunoprecipitation from phagosome extracts
Rabbit anti-MSR1 antibody and rabbit IgG were coupled to protein
A-Sepharose (Amersham Biosciences) by incubation in PBS for 5 h
at 4°C. Then, antibodies were cross-linked to the Sepharose by
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incubating with 20 mM dimethyl pimelimidate dihydrochloride
(DMP, Sigma) in 0.1 M sodium tetraborate decahydrate (Sigma) pH
9.3 for 30 min at room temperature. Excess antibody was removed
by washing the Sepharose in 50 mM glycine (Sigma) pH 2.5. The
resin was washed extensively with 0.2 M Tris–HCl pH 8.0. Phago-
somes were isolated from M2 (IL-4) macrophages using magnetic
beads. Phagosomal lysate of 500 lg was incubated with antibody
cross-linked Sepharose in cell lysis buffer for 5 h at 4°C. The beads
were washed three times with 1 ml of lysis buffer. Immunoprecipi-
tated proteins were eluted by denaturation in 1% LDS and subjected
to immunoblotting.
Preparation of oxLDL
Human low-density lipoprotein (Millipore) was oxidized by incubat-
ing at 1 mg/ml with 5 lM CuSO4 (Sigma) in PBS for 18 h at 37°C.
The oxidized low-density lipoprotein (oxLDL) was dialysed in a dial-
ysis cassette (Pierce) against PBS to remove CuSO4 and then added
to BMDMs at the desired concentration.
Quantitative real-time PCR
RNA was isolated from cells using RNeasy kit from Qiagen. Total
RNA (500–1,000 ng) was used to synthesize cDNA with the Quanti-
Tect Reverse Transcription Kit (Qiagen). Quantitative real-time PCR
analysis was performed using the iTaqTM Universal SYBR Green
Supermix and analysed using the CFX384 TouchTM Real-Time PCR
Detection System (Bio-Rad). The results were normalized to Gapdh
and expressed as fold change relative to RNA samples from control
or mock-treated cells using the comparative CT method (DDCT). The
following validated QuantiTect primer assays (Qiagen) were used:
Gapdh, Il1b and Tnfa.
Ccl2 was analysed using the following primer sequences: forward
primer: ATTCTGTGACCATCCCCTCAT; reverse primer: TGTATGT
GCCTCTGAACCCAC.
Flow cytometry analysis
M0 and M2 (IL-4) were incubated with fucoidan from Fucus vesicu-
losus (50 lg/ml; Sigma-Aldrich) and oxLDL (50 lg/ml) for 24 h,
after which cells were collected at 1 × 106 cells per tube into poly-
styrene tubes (Corning Incorporated). Cells in each tube were
washed twice in PBS/FBS (1% FBS in PBS, pH 7.2) by centrifugation
at 1,200 × g for 3 min and resuspended in 100-ll blocking buffer
(1–50 dilution of CD16/CD32 in PBS/FBS) to block Fc receptors.
Following 15-min incubation in ice, cells were washed once in PBS/
FBS and then incubated with 100 ll PBS/FBS containing 1–100 dilu-
tion of phycoerythrin (PE)-conjugated CD54, CD69, CD86, CD301b
or CD36 antibodies (eBioscience) for 30 min on ice, respectively.
PE-CD11b (eBioscience) was mixed with each antibody at 1–200
dilution as control. After washing for three times in PBS/FBS, cells
were analysed by flow cytometry.
JNK inhibitor treatment
BMDMs were pre-treated with 0.3 lM JNK7 or JNK8 inhibitor (Zhang
et al, 2012) 1 h before stimulation with 50 lM of fucoidan for the
indicated time (6 h—RT–PCR analysis, 24 h—FACS analysis).
Immunohistochemistry
Three-micrometre tissue sections from selected paraffin blocks of
primary human tumours were prepared. Slides were incubated over-
night at 56°C, deparaffinized in xylene for 20 min, rehydrated
through a graded ethanol series and washed with PBS. Immunohis-
tochemistry was performed on a Ventana Benchmark XT automatic
immunostaining device (Roche). A heat-induced epitope retrieval
step was performed in Ventana CC1 solution for 60 min. Primary
antibodies were incubated for 40, 60 and 120 min, respectively. An
Ultravision detection system was used.
Statistical analysis
Statistical analysis was performed using GraphPad Prism software.
Definition of statistical analysis and post hoc tests used can be found
in figure legends. The statistical significance of data is denoted on
graphs by asterisks (*) where *P < 0.05, **P < 0.01, ***P < 0.001
or ns = not significant.
Data availability
Mass spectrometric raw data are available through the PRIDE repos-
itory (https://www.ebi.ac.uk/pride/archive/) and have been
assigned the identifiers PXD010478 (TUBE pull-down data) and
PXD004520 (phagosome proteomic data).
Expanded View for this article is available online.
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